为GRADE推荐推导基线风险估计的建模方法:概念、开发及在ASH 2019外科住院患者VTE预防指南中的应用结果
本研究旨在开发一种建模方法,用于缺乏直接适用于优先患者重要结局的基线风险估计时。McMaster大学GRADE中心与ASH指南专家组基于对VTE事件症状分布、解剖位置和严重程度的明确假设开发了该方法,并应用于推导基线风险的建模估计,用于计算预期效应的绝对度量,支持了30条指南推荐的讨论与制定。
要点
- 建模方法基于对VTE症状分布、解剖位置和严重程度的明确假设。
- 建模估计用于计算预期效应的绝对度量,支持指南推荐制定。
- 该方法可帮助指南制定者应对缺乏直接适用基线风险估计的情况。
核心结论
- 该建模方法可帮助指南制定者应对缺乏直接适用于感兴趣结局的基线风险估计的情况。
- 使用建模估计增加了过程的透明度,并使指南专家在决策中使用的基线风险明确化。
研究设计与样本
- McMaster大学GRADE中心与ASH外科患者VTE预防指南专家组开发了基于明确假设的建模方法。
- 假设涉及VTE事件的症状分布、解剖位置和严重程度。
主要发现
- 应用该方法推导了基线风险的建模估计。
- 建模估计用于计算预期效应的绝对度量,支持了30条指南推荐的讨论与制定。
临床怎么用
- 在缺乏直接适用的基线风险估计时,指南制定者可考虑使用该建模方法推导估计。
- 建模估计可用于计算预期效应的绝对度量,支持证据讨论和推荐制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The goal of this study was to develop an approach that can be used where baseline risk estimates that are directly applicable to prioritized patient-important outcomes are not available from published studies. STUDY DESIGN: The McMaster University GRADE Centre and the ASH guideline panel for the prevention of VTE in surgical patients developed a modeling approach based on explicit assumptions about the distribution of symptoms, anatomical location, and severity of VTE events. RESULTS: We applied the approach to derive modeled estimates of baseline risk. These estimates were used to calculated absolute measures of anticipated effects that informed the discussion of the evidence and the formulation of 30 guideline recommendations. CONCLUSION: Our approach can assist guideline developers facing a lack of information about baseline risk estimates that directly apply to outcomes of interest. The use of modeled estimates increases transparency in the process and makes the baseline risk used by guideline experts explicit during their decision-making.
引用
- Morgano GP, Wiercioch W, Anderson DR, et al. A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients. J Clin Epidemiol. 2021. PMID: 34284102. doi:10.1016/j.jclinepi.2021.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。